专科姑息治疗对黑人及非西班牙裔白人转移性癌症老年患者终末期结局影响的异质性
该研究通过倾向性匹配队列分析黑人及非西班牙裔白人转移性癌症老年患者接受专科姑息治疗(PC)与终末期结局的关系。结果显示两组患者接受PC后临终关怀使用率均提高、ICU及化疗使用减少,且无统计学交互作用,提示PC疗效差异不解释终末期照护的种族差异。
要点
- 接受专科PC的黑人与非西班牙裔白人患者临终关怀使用率均显著提高。
- 专科PC与降低ICU使用及终末期化疗使用相关,且种族间无交互作用。
- PC疗效的种族异质性无证据,不解释终末期照护的种族差异。
核心结论
- 在转移性癌症老年患者中,专科PC对黑人及非西班牙裔白人患者的终末期结局影响无显著异质性。
研究设计与样本
- 倾向性匹配队列研究,1:1匹配后纳入13,931对接受与未接受专科PC的转移性癌症老年患者,其中黑人占13.4%。
主要发现
- 黑人患者接受PC后临终关怀使用率为71.0% vs 52.4%(p<0.0001),非西班牙裔白人为80.4% vs 63.2%(p<0.0001)。
- 黑人患者接受PC后临终关怀入组≥3天比例为65.5% vs 44.0%(p<0.0001),非西班牙裔白人为74.2% vs 52.6%(p<0.0001)。
- 黑人患者接受PC后ICU使用率为16.4% vs 19.9%(p=0.0058),非西班牙裔白人为11.3% vs 14.0%(p<0.0001)。
- 黑人患者接受PC后终末期化疗使用率为1.2% vs 2.4%(p=0.0075),非西班牙裔白人为1.4% vs 3.4%(p<0.0001)。
- 所有结局的相乘及相加交互作用检验均无统计学意义。
临床怎么用
- 专科姑息治疗可改善黑人与非西班牙裔白人转移性癌症老年患者的终末期照护质量。
- PC疗效的种族差异不显著,临床应确保所有符合条件的患者平等获得专科PC服务。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although racial disparities in end-of-life care exist, whether the effect of specialist palliative care (PC) on end-of-life outcomes differs by race is unknown. METHODS: We created a propensity-matched cohort of Black and non-Hispanic White (NHW) older adults with metastatic cancer who did and did not receive specialist PC in the last 6 months of life. End-of-life outcomes included hospice use, hospice enrollment ≥ 3 days, intensive care unit (ICU) use in the last 30 days of life, and use of chemotherapy in the last 14 days of life. We used Cox regression models to evaluate for the presence of interaction between specialist PC and race for all outcomes on the multiplicative scale using interaction terms, and on the additive scale using the relative risk due to interaction (RERI), attributable proportion (AP) and synergy index (SI). RESULTS: After 1:1 matching, 13,931 exposed and 13,931 unexposed older adults were included, of which 13.4% were Black. In comparison to those who did not receive specialist PC, both Black and NHW older adults who received specialist PC were more likely to use hospice (71.0% versus 52.4% for Black, p < 0.0001; 80.4% versus 63.2% for NHW, p < 0.0001), have hospice enrollment ≥ 3 days (65.5% versus 44.0% for Black, p < 0.0001; 74.2% versus 52.6% for NHW, p < 0.0001), and have less use of the ICU (16.4% versus 19.9% for Black, p = 0.0058; 11.3% versus 14.0% for NHW, p < 0.0001) or chemotherapy at the end-of-life (1.2% versus 2.4% for Black, p = 0.0075, 1.4% versus 3.4% for NHW, p < 0.0001). There was no evidence of multiplicative interaction or additive interaction for any outcome. CONCLUSION: In older adults with metastatic cancer, there was no evidence for heterogeneity of effect for specialist PC between Black and NHW patients, suggesting that differences in the efficacy of specialist PC are not responsible for racial disparities in end-of-life care.
引用
- Guo L, Murali KP, Morrison RS, et al. Heterogeneity of Effect of Specialist Palliative Care for Black and Non-Hispanic White Older Adults With Metastatic Cancer. J Am Geriatr Soc. 2025. PMID: 40566741. doi:10.1111/jgs.19587
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。